# FDA Inspection 984549 - Chongqing Daxin Pharmaceutical Co., Ltd. - August 04, 2016

Source: https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/694c754a-fecf-4d74-a161-a4f54ce33b26
Source feed: FDA_Inspections

> FDA Inspection 984549 for Chongqing Daxin Pharmaceutical Co., Ltd. on August 04, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 984549
- Company Name: Chongqing Daxin Pharmaceutical Co., Ltd.
- Inspection Date: 2016-08-04
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 829548 - 2013-04-18](https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/31798eea-e595-4356-9da9-977f526ea7a7)
- [FDA Inspection 616428 - 2009-08-06](https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/3bda4b6e-7fda-40fd-9214-e30f8c8c6050)

Company: https://www.keypedia.com/companies/chongqing-daxin-pharmaceutical-co-ltd/2d98394c-de0a-498c-bb6a-9a3a97f813eb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c